| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:06 | Capital One stock rating reiterated as Buy by TD Cowen on Discover deal | ||
| 16:06 | Burlington Stores price target lowered to $315 from $330 at TD Cowen | ||
| 15:54 | Challenger shareholders approve merger with Sintana Energy | ||
| 15:54 | Amber International announces $50 million share buyback program | ||
| 15:54 | Patria to acquire 51% stake in Brazilian CLO manager Solis | ||
| 15:42 | Mama's Creations stock rating reiterated at Buy by DA Davidson | ||
| 15:42 | Jefferies upgrades Fluence Energy stock rating to Hold on improving outlook | ||
| 15:42 | J.M. Smucker stock holds Neutral rating at DA Davidson after Q2 results | ||
| 15:42 | DA Davidson reiterates Buy rating on Best Buy stock, citing product cycles | ||
| 15:42 | Allstate stock price target raised to $240 from $230 at Roth/MKM | ||
| 15:42 | NetApp stock holds steady after solid Q2 results, Oppenheimer maintains Perform rating | ||
| 15:30 | Major shareholders withdraw $18 per share take-private bid for Grindr | ||
| 15:30 | CTS Corporation names Pratik Trivedi as new chief operating officer | ||
| 15:30 | Goldman Sachs discloses trading position in Avadel Pharmaceuticals | ||
| 15:30 | Goldman Sachs discloses trading in Permanent TSB shares | ||
| 15:30 | Aseana Properties plans $3.86 million share subscription at premium | ||
| 15:30 | Orion rejects Kawa's board nominees as invalid for 2026 meeting | ||
| 15:30 | Truist names Lo Li to lead consumer banking technology division | ||
| 15:30 | A2Z Smart Technology stock rises after Benchmark reiterates Buy rating | ||
| 15:30 | Benchmark reiterates Buy rating on Analog Devices stock, maintains $285 target | ||
| 15:18 | Republic Power receives Nasdaq non-compliance notice over delayed filing | ||
| 15:18 | Moleculin Biotech announces 1-for-25 reverse stock split | ||
| 15:18 | Allegiant to offer up to 40% off flights during 48-hour cyber sale | ||
| 15:18 | E.W. Scripps adopts shareholder rights plan after acquisition offer | ||
| 15:18 | XOMA Royalty to acquire Mural Oncology for $2.035 per share |